Gilbert Ho

5.4k total citations · 1 hit paper
48 papers, 2.4k citations indexed

About

Gilbert Ho is a scholar working on Physiology, Neurology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Gilbert Ho has authored 48 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Physiology, 18 papers in Neurology and 15 papers in Cellular and Molecular Neuroscience. Recurrent topics in Gilbert Ho's work include Alzheimer's disease research and treatments (24 papers), Parkinson's Disease Mechanisms and Treatments (13 papers) and Nuclear Receptors and Signaling (6 papers). Gilbert Ho is often cited by papers focused on Alzheimer's disease research and treatments (24 papers), Parkinson's Disease Mechanisms and Treatments (13 papers) and Nuclear Receptors and Signaling (6 papers). Gilbert Ho collaborates with scholars based in United States, Japan and China. Gilbert Ho's co-authors include Eliezer Masliah, Lawrence A. Hansen, Makoto Hashimoto, David P. Salmon, Leon J. Thal, Douglas Galasko, Masaaki Waragai, L. J. Thal, Gang Tong and James Fallon and has published in prestigious journals such as Journal of Biological Chemistry, Nature Medicine and Neurology.

In The Last Decade

Gilbert Ho

47 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease

2005 780 citations Gilbert Ho et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Gilbert Ho United States	21	1.1k	718	686	675	380	48	2.4k
Derya R. Shimshek Switzerland	30	949 0.9×	924 1.3×	1.0k 1.5×	683 1.0×	133 0.3×	54	3.0k
Claire E. Shepherd Australia	25	1.3k 1.3×	369 0.5×	802 1.2×	752 1.1×	402 1.1×	68	2.5k
Estibaliz Capetillo‐Zarate Spain	26	1.4k 1.4×	797 1.1×	791 1.2×	263 0.4×	245 0.6×	44	2.6k
Cheryl A. Hawkes United Kingdom	30	1.6k 1.5×	1.1k 1.5×	945 1.4×	968 1.4×	242 0.6×	61	3.8k
Margarita Carmona Spain	35	1.4k 1.3×	769 1.1×	1.3k 2.0×	707 1.0×	156 0.4×	60	3.1k
Henrietta M. Nielsen Sweden	28	1.5k 1.4×	423 0.6×	801 1.2×	595 0.9×	355 0.9×	45	2.8k
Kerstin Iverfeldt Sweden	30	927 0.9×	993 1.4×	1.2k 1.8×	232 0.3×	273 0.7×	57	2.9k
Diederik Moechars Belgium	28	1.9k 1.8×	1.1k 1.6×	1.3k 1.8×	480 0.7×	214 0.6×	53	3.8k
Giuseppina Tesco United States	27	1.4k 1.3×	619 0.9×	1.2k 1.7×	370 0.5×	111 0.3×	45	2.6k
Maria Luiza Gava Schmidt United States	25	1.6k 1.5×	677 0.9×	883 1.3×	1.3k 1.9×	298 0.8×	57	2.8k

Countries citing papers authored by Gilbert Ho

Since Specialization

Citations

This map shows the geographic impact of Gilbert Ho's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gilbert Ho with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gilbert Ho more than expected).

Fields of papers citing papers by Gilbert Ho

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gilbert Ho. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gilbert Ho. The network helps show where Gilbert Ho may publish in the future.

Co-authorship network of co-authors of Gilbert Ho

This figure shows the co-authorship network connecting the top 25 collaborators of Gilbert Ho. A scholar is included among the top collaborators of Gilbert Ho based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gilbert Ho. Gilbert Ho is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ho, Gilbert, et al.. (2022). Reconsideration of Alzheimer’s Disease Therapy from a Viewpoint of Amyloidogenic Evolvability. Journal of Alzheimer s Disease Reports. 6(1). 207–210. 2 indexed citations

Ho, Gilbert, et al.. (2021). Diabetes, inflammation, and the adiponectin paradox: Therapeutic targets in SARS-CoV-2. Drug Discovery Today. 26(8). 2036–2044. 13 indexed citations

Wei, Jianshe, Gilbert Ho, Yoshiki Takamatsu, Eliezer Masliah, & Makoto Hashimoto. (2021). Therapeutic Potential of α-Synuclein Evolvability for Autosomal Recessive Parkinson’s Disease. Parkinson s Disease. 2021. 1–11. 1 indexed citations

Wei, Jianshe, Yoshiki Takamatsu, Masayo Fujita, et al.. (2021). Therapeutic Potential of αS Evolvability for Neuropathic Gaucher Disease. Biomolecules. 11(2). 289–289. 4 indexed citations

Hashimoto, Makoto, Gilbert Ho, Shuei Sugama, et al.. (2021). Possible Role of Activin in the Adiponectin Paradox-Induced Progress of Alzheimer’s Disease. Journal of Alzheimer s Disease. 81(2). 451–458. 9 indexed citations

Takamatsu, Yoshiki, Gilbert Ho, & Makoto Hashimoto. (2020). Amyloid Evolvability and Cancer. Trends in cancer. 6(8). 624–627. 6 indexed citations

Hashimoto, Makoto, Gilbert Ho, Yoshiki Takamatsu, et al.. (2019). Possible Role of Amyloid Cross-Seeding in Evolvability and Neurodegenerative Disease. Journal of Parkinson s Disease. 9(4). 793–802. 11 indexed citations

Takamatsu, Yoshiki, Masayo Fujita, Gilbert Ho, et al.. (2018). Motor and Nonmotor Symptoms of Parkinson’s Disease: Antagonistic Pleiotropy Phenomena Derived fromα-Synuclein Evolvability?. Parkinson s Disease. 2018. 1–6. 14 indexed citations

Hashimoto, Makoto, Gilbert Ho, Yoshiki Takamatsu, et al.. (2018). Evolvability and Neurodegenerative Disease: Antagonistic Pleiotropy Phenomena Derived from Amyloid Aggregates. Journal of Parkinson s Disease. 8(3). 405–408. 24 indexed citations

10.

Waragai, Masaaki, Gilbert Ho, Yoshiki Takamatsu, et al.. (2018). Dual-therapy strategy for modification of adiponectin receptor signaling in aging-associated chronic diseases. Drug Discovery Today. 23(6). 1305–1311. 15 indexed citations

11.

Takamatsu, Yoshiki, Gilbert Ho, Shuei Sugama, et al.. (2017). Combined immunotherapy with “anti-insulin resistance” therapy as a novel therapeutic strategy against neurodegenerative diseases. npj Parkinson s Disease. 3(1). 4–4. 23 indexed citations

12.

Kawahara, Kohichi, Makoto Hashimoto, Pazit Bar‐On, et al.. (2008). α-Synuclein Aggregates Interfere with Parkin Solubility and Distribution. Journal of Biological Chemistry. 283(11). 6979–6987. 50 indexed citations

13.

Bar‐On, Pazit, Edward Rockenstein, Anthony Adame, et al.. (2006). Effects of the cholesterol‐lowering compound methyl‐β‐cyclodextrin in models of α‐synucleinopathy. Journal of Neurochemistry. 98(4). 1032–1045. 59 indexed citations

14.

Weisman, David, et al.. (2006). Interleukins, Inflammation, and Mechanisms of Alzheimer's Disease. Vitamins and hormones. 74. 505–530. 75 indexed citations

15.

Ho, Gilbert, et al.. (2005). Mechanisms of Cell Signaling and Inflammation in Alzheimers Disease. Current Drug Targets - Inflammation & Allergy. 4(2). 247–256. 161 indexed citations

16.

Masliah, Eliezer, Gilbert Ho, & Tony Wyss‐Coray. (2001). Functional role of TGFβ in Alzheimer's disease microvascular injury: lessons from transgenic mice. Neurochemistry International. 39(5-6). 393–400. 24 indexed citations

17.

Ho, Gilbert, Irina V. Smirnova, Mohammed Akaaboune, Daniel Hantaı̈, & Barry W. Festoff. (1994). Serine proteases and their serpin inhibitors in Alzheimer's disease. Biomedicine & Pharmacotherapy. 48(7). 296–304. 25 indexed citations

18.

Ho, Gilbert, Eugene Gregory, Irina V. Smirnova, Mikhail N. Zoubine, & Barry W. Festoff. (1994). Cross‐linking of β‐amyloid protein precursor catalysed by tissue transglutaminase. FEBS Letters. 349(1). 151–154. 49 indexed citations

19.

Smirnova, Irina V., Gilbert Ho, John W. Fenton, & Barry W. Festoff. (1994). Extravascular Proteolysis and the Nervous System: Serine Protease/Serpin Balance. Seminars in Thrombosis and Hemostasis. 20(4). 426–432. 18 indexed citations

20.

Yang, Shi, et al.. (1994). Insulin‐like growth factor binding protein‐1 at mouse neuromuscular synapses. Synapse. 17(4). 225–229. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact